|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/70 | |
| A61K 39/09 |
| (11) | Number of the document | 3444352 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18198665.4 |
| Date of filing the European patent application | 2013-11-07 | |
| (97) | Date of publication of the European application | 2019-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261723408 P | 2012-11-07 | US |
| (72) |
WACKER, Michael, CH
KOWARIK, Michael, CH
WETTER, Michael, CH
FARIDMOAYER, Amirreza, CH
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (54) | PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION |
| PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION |